Cleared Traditional

K213992 - CombiSet Hemodialysis Blood Tubing Set (FDA 510(k) Clearance)

May 2023
Decision
526d
Days
Class 2
Risk

K213992 is an FDA 510(k) clearance for the CombiSet Hemodialysis Blood Tubing Set. This device is classified as a Set, Tubing, Blood, With And Without Anti-regurgitation Valve (Class II - Special Controls, product code FJK).

Submitted by Fresenius Medical Care Renal Therapies Group, LLC (Waltham, US). The FDA issued a Cleared decision on May 31, 2023, 526 days after receiving the submission on December 21, 2021.

This device falls under the Gastroenterology & Urology FDA review panel. Regulated under 21 CFR 876.5820.

Submission Details

510(k) Number K213992 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 21, 2021
Decision Date May 31, 2023
Days to Decision 526 days
Submission Type Traditional
Review Panel Gastroenterology & Urology (GU)
Summary Summary PDF

Device Classification

Product Code FJK — Set, Tubing, Blood, With And Without Anti-regurgitation Valve
Device Class Class II - Special Controls
CFR Regulation 21 CFR 876.5820